We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+19.87%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
+$17.9M
Cap. Flow
+$6.34M
Cap. Flow %
5.37%
Top 10 Hldgs %
16.29%
Holding
285
New
33
Increased
176
Reduced
36
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 43.59%
2 Miscellaneous 16.64%
3 Technology 10.39%
4 Industrials 9.8%
5 Real Estate 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
151
Nasdaq
NDAQ
$54.2B
$217K 0.18%
2,756
+153
+6% +$13.4K
SION
152
Sionna Therapeutics
SION
$325M
$214K 0.18%
4,863
+45
+0.9% +$1.8K
VRSN icon
153
VeriSign
VRSN
$26.4B
$213K 0.18%
848
+46
+6% +$12.8K
AMD icon
154
Advanced Micro Devices
AMD
$780B
$211K 0.18%
364
+122
+50% +$50K
ITIC
155
Investors Title Co
ITIC
$563M
$209K 0.18%
+765
New +$185K
SSII
156
SS Innovations International
SSII
$683M
$208K 0.18%
50,000
WVE icon
157
Wave Life Sciences
WVE
$958M
$207K 0.18%
35,670
+6,495
+22% +$43.1K
RSG icon
158
Republic Services
RSG
$68.2B
$204K 0.17%
956
+53
+6% +$11.1K
MPC icon
159
Marathon Petroleum
MPC
$109B
$202K 0.17%
791
+38
+5% +$9.33K
EVR icon
160
Evercore
EVR
$11.5B
$202K 0.17%
592
+320
+118% +$109K
NTLA icon
161
Intellia Therapeutics
NTLA
$1.79B
$197K 0.17%
11,672
+166
+1% +$2.32K
CME icon
162
CME Group
CME
$101B
$196K 0.17%
887
+66
+8% +$18.3K
DG icon
163
Dollar General
DG
$29.4B
$195K 0.17%
1,698
+86
+5% +$9.77K
ROL icon
164
Rollins
ROL
$17.3B
$195K 0.16%
4,664
+260
+6% +$13.3K
COF icon
165
Capital One
COF
$135B
$195K 0.16%
970
-389
-29% -$74.4K
PAAS icon
166
Pan American Silver
PAAS
$21.3B
$194K 0.16%
4,335
+3,399
+363% +$182K
CDE icon
167
Coeur Mining
CDE
$21.8B
$191K 0.16%
11,732
+6,679
+132% +$122K
XRN
168
Chiron Real Estate Inc
XRN
$489M
$188K 0.16%
+5,000
New +$177K
B
169
Barrick Mining
B
$73.7B
$182K 0.15%
4,948
-1,225
-20% -$50.2K
EWT icon
170
iShares MSCI Taiwan ETF
EWT
$12.2B
$181K 0.15%
1,670
-533
-24% -$49.9K
RNA
171
Atrium Therapeutics
RNA
$243M
$181K 0.15%
13,478
+192
+1% +$2.51K
KGC icon
172
Kinross Gold
KGC
$36.6B
$177K 0.15%
7,504
-3,958
-35% -$116K
STX icon
173
Seagate
STX
$192B
$177K 0.15%
183
+9
+5% +$6.87K
CVS icon
174
CVS Health
CVS
$124B
$176K 0.15%
1,705
+90
+6% +$8.03K
GM icon
175
General Motors
GM
$77B
$176K 0.15%
2,288
+107
+5% +$8.41K

Similar funds

AlphaCentric Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, AlphaCentric Advisors held 285 positions worth $118M, up 18% from $100M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AlphaCentric Advisors deployed $6.34M of net new capital in Q2 2026, opening 33 new positions and adding to 176 existing holdings. Its largest new stake was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.41M trimmed.

  • AlphaCentric Advisors's largest Q2 2026 buy was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.
  • AlphaCentric Advisors added most to Synopsys in Q2 2026, an estimated $400K increase.
  • AlphaCentric Advisors's biggest Q2 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.41M.
  • AlphaCentric Advisors fully exited Whitestone REIT in Q2 2026, selling an estimated $460K.
  • AlphaCentric Advisors's ten largest holdings make up 16% of its $118M portfolio in Q2 2026.
  • AlphaCentric Advisors opened 33 new positions and closed 26 in Q2 2026.
  • AlphaCentric Advisors's portfolio value rose 18% quarter-over-quarter to $118M.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.